Emmessar Biotech & Nutrition has informed, pursuant to Regulation 29 (1) (a) of Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company will be held on Thursday the August 07, 2025, at Mumbai: To consider and approve unaudited Financial Results of the Company for the quarter ended June 30, 2025. Further, pursuant SEBI (Prohibition of Insider Trading), Regulations, 2015, as amended from time to time the Trading Window, as informed to the exchange vide letter dated 29.06.2025 in respect of trading in equity shares of the Company will remain closed upto August 09, 2025.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1702.60 |
| Dr. Reddys Lab | 1225.00 |
| Cipla | 1231.90 |
| Zydus Lifesciences | 947.60 |
| Lupin | 2338.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: